{"id":"https://openalex.org/W2613680501","doi":"https://doi.org/10.1158/1535-7163.mct-16-0624","title":"\u03b2-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma","display_name":"\u03b2-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma","alternate_titles":[],"publication_year":2017,"publication_date":"2017-09-01","ids":{"openalex":"https://openalex.org/W2613680501","doi":"https://doi.org/10.1158/1535-7163.mct-16-0624","mag":"2613680501","pmid":"https://pubmed.ncbi.nlm.nih.gov/28500235"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-16-0624","doi":"https://doi.org/10.1158/1535-7163.mct-16-0624","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-16-0624","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2613680501"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_-Catenin_Inhibitor_BC2059_Is_Efficacious_as_Monotherapy_or_in_Combination_with_Proteasome_Inhibitor_Bortezomib_in_Multiple_Myeloma/22508448","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084430732","display_name":"Ioanna Savvidou","orcid":"https://orcid.org/0000-0002-3911-9741","observed_orcids":["https://orcid.org/0000-0002-3911-9741"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ioanna Savvidou","raw_affiliation_strings":["1Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Hospital, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Hospital, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2801993434","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029778692","display_name":"Tiffany T. Khong","orcid":"https://orcid.org/0000-0002-9376-4223","observed_orcids":["https://orcid.org/0000-0002-9376-4223"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tiffany Khong","raw_affiliation_strings":["1Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Hospital, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Hospital, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2801993434","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047682972","display_name":"Andrew R. Cuddihy","orcid":"https://orcid.org/0000-0002-9898-0443","observed_orcids":["https://orcid.org/0000-0002-9898-0443"]},"institutions":[{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Cuddihy","raw_affiliation_strings":["2Division of Cancer Research Peter MacCallum Cancer Center, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Division of Cancer Research Peter MacCallum Cancer Center, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2800555584"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054461576","display_name":"Catriona McLean","orcid":"https://orcid.org/0000-0002-0302-5727","observed_orcids":["https://orcid.org/0000-0002-0302-5727"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catriona McLean","raw_affiliation_strings":["3Department of Anatomical Pathology, Alfred Hospital, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Anatomical Pathology, Alfred Hospital, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2801993434"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081120604","display_name":"Stephen K. Horrigan","orcid":"https://orcid.org/0000-0003-3055-7101","observed_orcids":["https://orcid.org/0000-0003-3055-7101"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen Horrigan","raw_affiliation_strings":["4BetaCat Pharmaceuticals, The University of Texas Health Science Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4BetaCat Pharmaceuticals, The University of Texas Health Science Center, Houston, Texas","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002073335","display_name":"Andrew G Spencer","orcid":"https://orcid.org/0000-0002-0531-7424","observed_orcids":["https://orcid.org/0000-0002-0531-7424"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]},{"id":"https://openalex.org/I4210163178","display_name":"Alfred Health","ror":"https://ror.org/04scfb908","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210163178"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Spencer","raw_affiliation_strings":["1Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Hospital, Melbourne, Victoria, Australia","5Malignant Haematology & Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Victoria, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Myeloma Research Group, Australian Centre for Blood Diseases, Monash University/Alfred Hospital, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2801993434","https://openalex.org/I56590836"]},{"raw_affiliation_string":"5Malignant Haematology & Stem Cell Transplantation Service, Alfred Hospital, Melbourne, Victoria, Australia","institution_ids":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.6296,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.93728127,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"16","issue":"9","first_page":"1765","last_page":"1778"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10929","display_name":"Wnt/\u03b2-catenin signaling in development and cancer","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-catenin-inhibitor","display_name":"\u03b2-catenin inhibitor","score":0.8899999856948853},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9869999885559082},{"id":"https://openalex.org/keywords/wnt-beta-catenin-signaling","display_name":"Wnt/\u03b2-catenin signaling","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.968999981880188},{"id":"https://openalex.org/keywords/proteasome-inhibitor-combination","display_name":"proteasome inhibitor combination","score":0.8019999861717224},{"id":"https://openalex.org/keywords/axin2","display_name":"Axin2","score":0.9789999723434448},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7459999918937683},{"id":"https://openalex.org/keywords/xenograft-tumor-growth","display_name":"xenograft tumor growth","score":0.7929999828338623},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.9113712906837463},{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.8125371932983398},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.7936557531356812},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7688133716583252},{"id":"https://openalex.org/C30145163","wikidata":"https://www.wikidata.org/wiki/Q384104","display_name":"Catenin","level":4,"score":0.6325969696044922},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6310819983482361},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5749887228012085},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.5499300360679626},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.5295487642288208},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4715079367160797},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41267716884613037},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3829350471496582},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2627391219139099},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2392171025276184},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.19781753420829773},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08509603142738342},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069286","descriptor_name":"Bortezomib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008822","descriptor_name":"Mice, Transgenic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015533","descriptor_name":"Transcriptional Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051176","descriptor_name":"beta Catenin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051176","descriptor_name":"beta Catenin","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051176","descriptor_name":"beta Catenin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055785","descriptor_name":"Gene Knockdown Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061988","descriptor_name":"Proteasome Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-16-0624","doi":"https://doi.org/10.1158/1535-7163.mct-16-0624","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-16-0624","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:28500235","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28500235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/22508448","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_-Catenin_Inhibitor_BC2059_Is_Efficacious_as_Monotherapy_or_in_Combination_with_Proteasome_Inhibitor_Bortezomib_in_Multiple_Myeloma/22508448","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/22508448","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_-Catenin_Inhibitor_BC2059_Is_Efficacious_as_Monotherapy_or_in_Combination_with_Proteasome_Inhibitor_Bortezomib_in_Multiple_Myeloma/22508448","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1482992061","https://openalex.org/W1967058999","https://openalex.org/W1969097053","https://openalex.org/W1969938783","https://openalex.org/W1971085650","https://openalex.org/W1983717821","https://openalex.org/W1983755269","https://openalex.org/W1993369755","https://openalex.org/W2006946954","https://openalex.org/W2017763753","https://openalex.org/W2018674722","https://openalex.org/W2019230169","https://openalex.org/W2023192965","https://openalex.org/W2025777952","https://openalex.org/W2031321792","https://openalex.org/W2032616537","https://openalex.org/W2038063884","https://openalex.org/W2054080205","https://openalex.org/W2071781451","https://openalex.org/W2080691032","https://openalex.org/W2084421367","https://openalex.org/W2090792585","https://openalex.org/W2119780609","https://openalex.org/W2125347681","https://openalex.org/W2134188318","https://openalex.org/W2138035935","https://openalex.org/W2138189569","https://openalex.org/W2139920251","https://openalex.org/W2145978712","https://openalex.org/W2148001945","https://openalex.org/W2155507705","https://openalex.org/W2158021558","https://openalex.org/W2167780668","https://openalex.org/W2218222358","https://openalex.org/W3195431600","https://openalex.org/W4252175385"],"related_works":["https://openalex.org/W2586214774","https://openalex.org/W155835975","https://openalex.org/W2556460527","https://openalex.org/W2372859029","https://openalex.org/W3162358813","https://openalex.org/W2526450722","https://openalex.org/W2525735426","https://openalex.org/W3205905626","https://openalex.org/W2560657281","https://openalex.org/W4310598099"],"abstract_inverted_index":{"Currently":[0],"available":[1],"treatment":[2,248],"options":[3],"are":[4],"unlikely":[5],"to":[6,45],"be":[7,46],"curative":[8],"for":[9,20,37,61,246],"the":[10,21,59,63,98,108,111,114,118,122,153,158,184,219,223,247],"majority":[11],"of":[12,23,55,86,97,117,124,131,200,221,244,249],"multiple":[13,49,166,193,250],"myeloma":[14,90,167,194],"patients,":[15],"emphasizing":[16],"a":[17,141],"continuing":[18],"role":[19],"introduction":[22],"investigational":[24],"agents":[25],"that":[26],"can":[27],"overcome":[28],"drug":[29],"resistance.":[30],"The":[31],"canonical":[32,99],"Wnt/\u03b2-catenin":[33,224],"signaling":[34],"pathway,":[35],"essential":[36],"self-renewal,":[38],"growth,":[39],"and":[40,70,78,110,121,137,191,207,231],"survival,":[41],"has":[42],"been":[43],"found":[44],"dysregulated":[47],"in":[48,52,71,76,79,88,106,140,148,164,169,189,197,229,232],"myeloma,":[50],"particularly":[51],"advanced":[53],"stages":[54],"disease.":[56],"This":[57,144],"provides":[58],"rationale":[60],"evaluating":[62],"novel":[64],"\u03b2-catenin":[65,87,104],"inhibitor":[66,186],"BC2059":[67,102,134,161,203,227,245],"as":[68],"monotherapy":[69],"combination":[72],"with":[73,95,133,183,210,226],"proteasome":[74,185],"inhibitors":[75],"vitro":[77,230],"vivo.":[80],"Here,":[81],"we":[82],"show":[83],"nuclear":[84],"localization":[85],"human":[89,201],"cell":[91,150],"lines":[92],"(HMCL),":[93],"consistent":[94],"activation":[96],"Wnt":[100],"pathway.":[101],"attenuates":[103],"levels,":[105],"both":[107,188,228],"cytoplasm":[109],"nucleus,":[112],"reducing":[113],"transcriptional":[115],"activity":[116],"TCF4/LEF":[119],"complex":[120],"expression":[123],"its":[125],"target":[126],"gene":[127],"axin":[128],"2.":[129],"Treatment":[130],"HMCL":[132,190],"inhibits":[135],"proliferation":[136],"induces":[138,162],"apoptosis":[139,163,173],"dose-dependent":[142],"manner.":[143],"is":[145],"also":[146],"observed":[147],"HMCL\u2013stromal":[149],"cocultures,":[151],"mitigating":[152],"protective":[154],"effect":[155],"afforded":[156],"by":[157],"stroma.":[159],"Similarly,":[160],"primary":[165,192],"samples":[168],"vitro,":[170],"causing":[171],"minimal":[172],"on":[174],"healthy":[175],"peripheral":[176],"blood":[177],"mononuclear":[178],"cells.":[179],"Furthermore,":[180],"it":[181],"synergizes":[182],"bortezomib":[187],"samples.":[195],"Finally,":[196],"xenograft":[198],"models":[199],"myelomatosis,":[202],"delays":[204],"tumor":[205],"growth":[206],"prolongs":[208],"survival":[209],"minor":[211],"on-target":[212],"side":[213],"effects.":[214],"Collectively,":[215],"these":[216],"results":[217],"demonstrate":[218],"efficacy":[220],"targeting":[222],"pathway":[225],"vivo,":[233],"at":[234],"clinically":[235],"achievable":[236],"doses.":[237],"These":[238],"findings":[239],"support":[240],"further":[241],"clinical":[242],"evaluation":[243],"myeloma.":[251],"Mol":[252],"Cancer":[253],"Ther;":[254],"16(9);":[255],"1765\u201378.":[256],"\u00a92017":[257],"AACR.":[258]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2613680501","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-05-19T00:00:00"}
